Over the last decade significant advances have been made in our understanding of the molecular mechanisms that control early aspects of mammalian liver development. Studies using tissue explant cultures and molecular biology techniques as well as the analysis of transgenic and knockout mice have identified signaling molecules and transcription factors that are necessary for the onset of hepatogenesis. This review presents an overview of these studies and discusses the role of individual factors during hepatic development. q
Introduction
The liver is a large glandular organ comprising one fiftieth of the total weight of the adult body. In human, it consists of two major lobes that are subdivided into smaller segments. It has a unique position within the body in that it receives venous blood directly from the intestine, spleen and pancreas and, as such, encounters a diverse array of toxins, nutrients and hormones. Reflecting this anatomical position the liver performs endocrine functions that condition the blood through detoxification and the secretion of serum factors. This requires communication between the basal surface of the hepatocyte and the afferent blood supply. This is facilitated by a complex liver architecture that consists of anastomosing plates of hepatocytes whose basal surfaces face a network of sinusoidal capillaries. In addition to its endocrine activity, the liver also exhibits an exocrine function through the generation of bile. The bile is secreted across the hepatocyte's apical surface into canaliculi that join bile ducts, which carry bile through the hepatic duct to the gallbladder. The architecture of the liver is absolutely critical for normal liver function and is often severely affected during chronic liver injury (Friedman, 2000) . During embryonic development, it is, therefore, crucial that the various differentiated hepatic cell types combine with extracellular components and connective tissues to generate a functional hepatic infrastructure. The cellular composition of the liver is less complex than the anatomical constitution. Approximately 60% of cells in the adult rat liver are hepatocytes, while the remaining cells consist largely of cholangiocytes, Kuppfer cells, stellate cells, and a variety of endothelial cells including those lining the sinusoids (sinusoidal endothelial cells) (Blouin et al., 1977) . Although the hepatocyte constitutes the bulk of the parenchyma, it is now clear that communication between hepatocytes and non-parenchymal cells is essential for normal liver function (Kmiec, 2001) . Historically, the majority of studies concerning liver development have focused on understanding differentiation of the hepatocyte lineage. Recently, however, advances have also been made in understanding the mechanisms controlling bile duct development. For example, mice lacking either of the transcription factors Hnf6 or Hnf1b in the liver affect development of the biliary cell lineages but have little impact on hepatocyte differentiation (a detailed review of the study of bile duct development has been provided by Le Maigre in the current issue) (Clotman et al., 2002; Coffinier et al., 2002) . Through the combined use of molecular genetic, tissue explant culture and molecular biological techniques, great advances have been made in our understanding of the mechanisms that control the onset of liver development, and it is the aim of this review to summarize these advances.
Descriptive overview of development of the liver
As shown in Fig. 1 , development of the liver can first be easily identified morphologically around the 14-20 somite stage as an outgrowing bud of proliferating endodermal cells present in the ventral floor of the foregut (LeDouarin, 1975) . At this early stage the bud is separated from the surrounding septum transversum mesenchyme by basement membrane (Medlock and Haar, 1983) . Following formation of the primary bud this basement membrane is progressively disrupted and the pre-hepatic cells delaminate from the foregut and migrate as cords into the surrounding septum transversum (LeDouarin, 1975; Medlock and Haar, 1983) . These pre-hepatic cells are commonly referred to as hepatoblasts. Although no direct lineage tracing studies have been reported, analyses of hepatoblasts in culture suggest that they are bipotential, capable of giving rise to both hepatocyte and cholangiocyte cell lineages (Blouin et al., 1995; Rogler, 1997; Spagnoli et al., 1998) . As the hepatoblasts migrate they closely associate with primitive sinusoidal endothelial cells that are seen to form capillary-like structures between the migrating hepatic cords (Enzan et al., 1997; Medlock and Haar, 1983) . Between 12-14 days gestation in the mouse, sinusoidal structure becomes more firmly established although initially the breaks and fenestrations associated with the adult sinusoidal endothelium are absent (Enzan et al., 1997) . Prior to day 12 of gestation in the mouse the hepatoblasts remain in a morphologically undifferentiated state (Medlock and Haar, 1983) . They have an irregular shape, large nuclear to cytoplasmic ratio and relatively few organelles when compared to the mature hepatocyte (Luzzatto, 1981; Medlock and Haar, 1983) . Junctional complexes between the hepatoblasts are lost following delamination from the foregut. However, electron microscopy has revealed the existence of random, presumably temporary, adhesions between hepatoblasts and also between hepatoblasts and the surrounding mesenchymal cells (Medlock and Haar, 1983) . This may imply that direct cell-cell communications occur during hepatoblast migration. The process of differentiation of hepatoblast to hepatocyte is gradual, taking several days during development of the rodent embryo. Electron microscopy of fetal rat tissues has shown that the cells transit from an oblong shape at day 12-14 of gestation to spherical around day 18 and finally become polygonal just prior to birth on day 20 (Vassy et al., 1988) . The changing ultrastructure of the hepatocyte during this developmental time frame reflects the ongoing differentiation process. Increases in rough endoplasmic reticulum and Golgi apparatus reflect the onset of synthesis of secreted proteins around rat embryonic day 12, while deposition of glycogen rosettes and the presence of peroxysomes are identifiable after embryonic day 18 in the rat (Luzzatto, 1981; Medlock and Haar, 1983) . The establishment of the hepatocyte cell polarity that is crucial in generating a functioning hepatic parenchyma begins relatively early in development. Bile canaliculi that represent the apical surface of the hepatocyte can first be detected around day 12 of gestation in the rat (Luzzatto, 1981; Wood, 1965) . However, at this stage they are infrequent and rarely have microvilli, indicating that they have yet to mature (De Wolf-Peeters et al., 1974; Montesano et al., 1975; Wood, 1965) . Moreover, few hepa- Fig. 1 . Induction of hepatogenesis by FGFs and BMPs. Upper panels diagram the processes that generate the liver primordia. Around the 7 somite stage of development the foregut endoderm (black) has invaginated and the ventral portion lies next to the developing pre-cardiac mesoderm (red). Initial stages of hepatogenesis require FGFs secreted from the pre-cardiac mesoderm and BMPs from the septum transversum mesenchyme (yellow) By 14 somites a swelling in the ventral endoderm generates the liver bud. Expansion of the liver primordia requires secretion of BMPs from the septum transversum mesenchyme and the action of unknown factors (??) from endothelial cells (cyan). White dashed line shows plane and position of section shown below in panel B. Lower panels A and B show hematoxylin and eosin stained sections from embryos at the developmental stages described in the diagram above. (A) Saggital section through an E8.25 mouse embryo, (B) transverse section through an embryo at E9.0 -a, anterior endodermal lip; c, precardiac mesoderm; en, ventral endoderm; e, endothelial cells; l, liver bud; s, septum transversum mesenchyme.
toblasts are in direct contact with each other during midgestation stages because of the abundance of hematopoietic cells in the liver from embryonic day 12 onward. This means that the extent of epithelial formation is minimal until late developmental stages (Feracci et al., 1987; Montesano et al., 1975; Wood, 1965) . Indeed, although the neonatal rat liver is functional it continues to develop and mature especially with regard to expression of liver enzymes (Burch et al., 1963; Greengard, 1969; Nemeth, 1954 The first investigations into the mechanisms underlying liver development, addressed the nature of the tissue interactions that were necessary for this process. Using the chick as an experimentally manipulable model, Nicole Le Douarin demonstrated that the inductive events, which result in hepatogenesis, occur in two steps. This was demonstrated by heterotypic grafts of quail tissues into donor chick embryos at different stages of development and by fate mapping using carbon particles (LeDouarin, 1975) . The first step occurs between the 5 and 7 somite stage and results in the ventral endoderm becoming specified to adopt a hepatic fate (Fig. 1) . Importantly, studies in which different tissues were cultured in varying combinations showed that the ventral endoderm had to be in close contact with precardiac splanchnic mesoderm for it to follow a hepatic fate (Fukuda, 1979; Fukuda-Taira, 1981; LeDouarin, 1975) . This is consistent with morphogenic movements during this stage in development that result in the invagination of the foregut, thereby juxtapositioning the ventral wall of endoderm with the developing heart. While this inductive property of the precardiac mesoderm was necessary for determination of the hepatic lineage it was not sufficient for hepatocyte differentiation. Further grafting experiments demonstrated that at the 20-22 somite stage a second stimulation by the septum transversum mesenchyme occurred that was required for proliferation and complete differentiation of the hepatocytes (LeDouarin, 1964 (LeDouarin, , 1968 (LeDouarin, , 1975 . Interestingly these culture experiments demonstrated that this second stimulation was not restricted to the septum transversum mesenchyme but a property of all mesenchymes derived from the lateral plate mesoderm. In contrast, non-lateral plate mesenchyme, for example cephalic and dorsal trunk mesenchyme, was incapable of supporting hepatic development (LeDouarin, 1975) .
More recently these key events controlling development of the liver have been confirmed in the mouse (Gualdi et al., 1996; Houssaint, 1980) . Gualdi et al. used reverse transcriptase-polymerase chain reaction (RT-PCR) analyses of isolated tissue samples to show that albumin mRNA, a characteristic marker of hepatic specification, could first be detected in the ventral endoderm at the 7-8 somite stage of mouse embryonic development (Cascio and Zaret, 1991; Gualdi et al., 1996) . By combining these tissue explant culture techniques with RT-PCR analysis, the authors confirmed that pre-cardiac mesoderm could induce the onset of hepatic development within the ventral endoderm. In addition, they found that dorsal endoderm, which normally follows an intestinal fate, would also express hepatic genes if cultured in the absence of surrounding mesoderm and ectoderm. This implied that dorsal endoderm was competent to adopt a hepatic developmental program and that this program was normally inhibited by the surrounding tissues. Indeed, support for this proposal came from the demonstration that dorsal tissues could inhibit the onset of hepatic development when cultured along with ventral endoderm/cardiac mesoderm mixtures (Gualdi et al., 1996) .
The availability of a culture assay and a sensitive technique to measure specification of hepatic fate facilitated a search for hepatic inducing factors (Jung et al., 1999; Rossi et al., 2001) . The fact that close contact between endoderm and cardiac mesoderm was a pre-requisite for hepatic specification implied that the inducing factors were likely to be either cell surface molecules or short range effectors expressed by the precardiac mesoderm (Gualdi et al., 1996; LeDouarin, 1975) . In this regard the fibroblast growth factors (FGFs) were good candidates because several are expressed in the developing heart and their range of action is limited by their high affinity for extracellular matrix (Crossley and Martin, 1995; Jung et al., 1999; Parlow et al., 1991; Szebenyi and Fallon, 1999; Zhu et al., 1996) . To directly test whether FGFs acted as hepatogenic signals Jung et al. isolated ventral endoderm from 2 to 6 somite stage embryos and cultured it in the presence or absence of FGF-1, -2 or 8b. The authors found that both FGFs-1 and -2 could effectively substitute for the precardiac mesoderm in inducing liver gene expression in the endoderm (Jung et al., 1999) . Moreover, although FGF8b failed to induce hepatic development it was found to contribute toward the morphogenic outgrowth of the hepatic tissue following specification. The results from these studies definitively established a role for the cardiac mesoderm and implicated FGFs in inducing the onset of hepatogenesis within the ventral endoderm (Fig. 1) .
Investigations by Deutsch et al. showed that at early somite stages of development the ventral endoderm has potential not only to follow a hepatic fate but that it can also adopt a pancreatic cell fate (Deutsch et al., 2001) . This observation raised the question of how the decision to follow either of these two fates was controlled. Answers came from similar tissue explant culture experiments. When the ventral endoderm was cultured in the absence of FGF or cardiac mesoderm, it was surprisingly found to initiate expression of pancreatic genes. However, if FGF2 or cardiac mesoderm was added to these cultures, as had been described previously, the endoderm expressed liver genes at the expense of the pancreatic genes. These data imply that the default fate of the ventral endoderm is to develop into pancreas and that FGF secreted locally by the cardiac mesoderm represses this fate and instead induces liver development. Microdissection of the ventral endoderm showed that the ventral pancreatic bud derives from the most anterior lip of endoderm that extends away from the developing heart, while the liver bud develops from the neighboring posterior portion of endoderm that juxtaposes the heart (Fig. 1) . Presumably, because the anterior lip of endoderm extends beyond the immediate vicinity of the cardiac mesoderm it encounters concentrations of FGF that are insufficient to induce hepatogenesis and, therefore, becomes pancreas. These results clearly reinforce the concept that embryonic development is a dynamic procedure that combines morphogenic movements with cell signaling to control patterning along the body axes.
The role of the septum transversum mesenchyme
The septum transversum originates from lateral plate mesoderm and gives rise to the epicardium of the heart and also the diaphragm. Although early transplantation studies had implicated this tissue as having an important role in controlling hepatocyte differentiation and promoting outgrowth of the hepatic tissue, the septum transversum had not been implicated in the earlier inductive events. However, recent work from Rossi et al. challenges this perception and suggests that the septum transversum mesenchyme may collaborate with developing cardiac tissue to control specification of the liver lineage (Rossi et al., 2001) . The authors used 'knock-in' mouse embryos that contained a LacZ reporter transgene whose expression was controlled by Bmp4 transcriptional regulatory elements. Analyses of 8 somite stage embryos identified high levels of Bmp4
LacZ expression within the septum transversum mesenchyme, implying a possible role for BMP4 signaling during the onset of hepatogenesis. Support for such a role came from two sets of experiments. Firstly, Noggin, an antagonist of BMP action, was found to inhibit the onset of albumin mRNA expression in co-cultures of cardiac tissue and 2-6 somite stage ventral endoderm. Secondly, hepatic specification was delayed and the liver bud failed to expand in Bmp4 2/2 mouse embryos. The observation that hepatic induction took place at all in Bmp4 2/2 mouse embryos is probably due to functional redundancy. Other BMP family members are expressed in the vicinity of the ventral foregut at this stage in development and could potentially complement the loss of BMP4 in Bmp4 2/2 mouse embryos. The fact that noggin inhibited induction of hepatic development seemed to contradict earlier findings that FGF alone was sufficient to induce hepatogenesis within cultured ventral endoderm (Jung et al., 1999) . However, when ventral endoderm explants were stained for expression of Mrg1, a marker of septum transversum mesenchyme, it was found that the endoderm cultures contained small numbers of Mrg1 positive mesenchymal cells. It seemed likely, in retrospect, that contaminating cells supplied enough BMPs to allow hepatic induction by exogenously added FGFs (Rossi et al., 2001) . In addition to induction of hepatogenesis, secretion of BMPs by the septum transversum mesenchyme seems to be critical for outgrowth of the nascent hepatoblasts (Rossi et al., 2001) . Cumulatively, these data suggest a model whereby FGFs and BMPs act in concert on the ventral foregut endoderm to direct the onset of hepatogenesis (Fig. 1 ). There are precedents for the coordinated action of FGFs and BMPs in the development of other organ systems. For example, BMP and FGFs also act cooperatively to induce cardiogenesis in the embryonic mesoderm during chick development (Barron et al., 2000; Lough et al., 1996) .
As discussed in the previous section, tissue grafting studies had shown that the septum transversum is also required for complete differentiation of hepatocytes (Houssaint, 1980; LeDouarin, 1968 LeDouarin, , 1975 . While the molecular nature of this event has yet to be elucidated it is possible that it results from a juxtacrine interaction of hepatoblasts with septum transversum-derived extracellular matrix. The fact that the presence and composition of extracellular matrix has a significant effect on the profile of genes expressed by cultured primary hepatocytes lends credence to this this model (Ben-Ze'ev et al., 1988; Caron, 1990; Clayton et al., 1985; DiPersio et al., 1991; Kim et al., 1998; Michalopoulos et al., 2001; Sanchez et al., 2000; Stamatoglou and Hughes, 1994) . The ECM matrix could regulate differentiation indirectly by binding and concentrating signaling molecules such as FGFs and WNTs. ECM components could also directly mediate intracellular signaling through interaction with integrins and induction of focal adhesion kinase (Fak) and other signaling complexes (Schwartz, 2001) . Further data implicating a role for ECM signaling during development of the liver come from studies of integrin function in both cultured cells and knockout mice. Integrins bind the extracellular matrix as heterodimers consisting of different combinations of a and b subunits. b1 integrin knockout mice die early in development prior to the onset of hepatogenesis, and so could not be used to study the impact on the developing liver (Fassler and Meyer, 1995; Stephens et al., 1995) . However, analysis of chimeric mice generated by combining wild type embryos with b1 integrin 2/2 ES cells found that cells lacking b1 integrin were incapable of colonizing the liver. This result implies that there is a cell autonomous requirement for b1 integrin in defining or maintaining the hepatocyte cell lineage (Fassler and Meyer, 1995) . In addition, studies using a hepatic cell line that can differentiate in response to cues from the ECM have shown that inhibiting expression of the a3 integrin subunit prevented this ECM-induced differentiation (Lora et al., 1998) .
Signals between mesenchymal cells, such as those of the septum transversum, and epithelial cells, such as hepatoblasts, that control diverse development procedures have been well documented (Birchmeier and Birchmeier, 1993) . While many of these signals control differentiation, as discussed above, some also control growth of the devel-oping liver (Duncan, 2000; Zaret, 1998) . Between days E13 and E20 of rat development the liver expands in volume by 84-fold and each hepatoblast undergoes approximately eight doublings (Greengard et al., 1972; Grisham and Thorgeirsson, 1996; Vassy et al., 1988) . One pathway that controls proliferation of the fetal liver involves hepatocyte growth factor (HGF). HGF is a potent mitogen that also affects cell migration and motility by signaling through its transmembrane tyrosine kinase receptor cMet. In situ hybridization studies showed that both ligand and receptor are expressed as early as E11.5 in the developing mouse liver as well as in other developing organs (Sonnenberg et al., 1993a,b) . It was proposed that the HGF/cMet pathway mediated crosstalk between mesenchyme and epithelial cells during development because HGF is expressed in mesenchymal cells while cMet is expressed in neighboring epithelial cells within the developing organs (Sonnenberg et al., 1993a,b) . Proliferation and outgrowth of the liver cells was directly shown to require HGF/cMet communication by the study of HGF and cMet knockout mouse embryos. Embryos lacking either HGF or cMet had similar phenotypes including severely hypoplastic livers due to the loss of parenchymal cells by E14.5 Schmidt et al., 1995; Uehara et al., 1995) . Recently, Michalopoulos et al. described a culture system in which monolayers of hepatocytes, hepatic mesenchymal cells and endothelial cells undergo a transition to form structures resembling a normal hepatic architecture (Michalopoulos et al., 1999) . Using this organoid culture system they demonstrated that the combined action of dexamethasone, epidermal growth factor (EGF) and HGF were required for maturation and formation of connective tissues (Michalopoulos et al., 2001 ). This implies that HGF not only is required for cell proliferation but also may mediate formation of a normal hepatic architecture during development.
Other signaling molecules acting on the developing hepatocytes may include transforming growth factor b (TGF-b). Binding of TGF-b to its receptors results in the dimerization of Smad 2 or Smad 3 with Smad 4 and accumulation of the dimeric complex in the nucleus. Here the complex acts as a transcription factor to regulate expression of TGF-b target genes (Massague and Chen, 2000) . Liver development was found to be severely perturbed in Smad2
mouse embryos at E14.5 (Weinstein et al., 2001) . Although expression of a number of hepatic lineage marker genes was unaffected, the mutant livers were dramatically hypoplastic. Liver cell proliferation was reduced to 34% of control livers and, in addition, Smad2 1/2 ; Smad3 1/2 livers exhibited increased apoptotic cell death. Liver architecture was also disrupted in the mutant embryos and the developing hepatic cells appeared unable to generate normal cell-cell adhesions. Studies of integrin gene expression showed that b1 integrin levels were 10% of controls. This is highly provocative given the evidence discussed above supporting a role for b1 integrin in controlling hepatogenesis. Interestingly, the phenotype associated with cultured Smad2 1/2 ; Smad3 1/2 livers could be rescued by HGF, implying that the two pathways converge to control a common aspect of hepatogenesis, possibly by regulating b1 integrin expression (Weinstein et al., 2001) . Further evidence supporting a role for the septum transversum mesenchyme in controlling developmental growth of the liver was revealed through the generation of Hlx knockout embryos. Hlx encodes a divergent homeobox transcription factor whose expression in the developing liver is restricted to cells derived from the septum transversum (Hentsch et al., 1996; Lints et al., 1996) . Mouse embryos lacking the Hlx gene initiated development of the liver normally, however, by E15.5 the mutant livers had failed to expand and reached only 3% of the size of control livers (Hentsch et al., 1996) . Although targets of the Hlx transcription factor have not been defined the knockout data imply that it is required for expression of factors that act in a paracrine fashion to control hepatogenesis. It will be interesting to determine whether Hlx can directly regulate expression of genes encoding growth factors, such as HGF or TGF-b, which are known to be essential for hepatic development.
The evidence discussed above overwhelmingly supports a central role for the septum transversum mesenchyme and its derivatives in multiple aspects of hepatogenesis. However, it is also clear that the pathways acting to control hepatoblast proliferation and differentiation, that emanate from this tissue are complex and intertwined. The recent identification of genes that mark the septum transversum cells as well as the increasing availability of mouse strains harboring null and conditionally null alleles will no doubt help unravel the specific mechanisms used by the septum transversum to control hepatic development.
Endothelial cells
At around E9.5, as the future parenchymal cells expand into the septum transversum from the liver bud they intersperse with endothelial cells that form simple continuous vessels (Bankston and Pino, 1980; Sherer, 1975) . As development proceeds, the morphology of the endothelial cells changes, becoming fenestrated and forming endothelial sheets that line the hepatic sinusoids (Bankston and Pino, 1980; Enzan et al., 1997) . The fact that endothelial cells are so closely associated with early developing hepatoblasts prompted Matsumo et al. to address whether endothelial cells played a role in controlling any aspect of hepatogenesis (Matsumoto et al., 2001 ). They did this by utilizing Flk-1 2/2 mouse embryos that are unable to generate mature endothelial cells or blood vessels (Shalaby et al., 1997 (Shalaby et al., , 1995 . In control mice, as early as E8.5 just as the liver bud is first discernable, immunohistochemical detection of PE-CAM, a definitive endothelial cell marker, identified the presence of endothelial cells lying between the liver bud and septum transversum. As expected, in Flk-1 2/2 embryos no endothelial cells were found in this region. When development of the liver was compared between control and Flk-1 2/2 embryos it was discerned that although hepatic specification had occurred hepatogenesis failed shortly thereafter with no indication of expansion or morphogenic movement of the hepatoblasts into the surrounding septum transversum. Expression of Flk-1 is restricted to the endodethelial cells and is absent from either septum transversum or hepatic endoderm. This implies that loss of the endothelial cells within the vicinity of the liver diverticulum is responsible for the arrest in hepatogenesis observed in Flk-1 2/2 embryos. Further support for an endothelial cell requirement in regulating hepatogenesis came from studying the growth of liver bud explants in culture (Matsumoto et al., 2001) . Liver buds containing mesenchymal, endodermal and endothelial cells were isolated from normal mouse embryos at E9.5 and cultured either in control medium or in medium supplemented with an angiogenesis inhibitor called NK4. Control cultures formed an extensive network of endothelial cells as well as an expanded region of fibroblasts, which were presumably derived from the septum transversum, and albumin positive hepatic cells. In contrast, growth of the vascular network was inhibited in cultures containing NK4 and the ratio of hepatoblasts to fibroblasts was significantly diminished (Matsumoto et al., 2001) . Cumulatively, these data suggest that signals from the endothelial cells surrounding the early liver bud are necessary to support hepatic morphogenesis. A clear aim for the future will be to determine which endothelial cell-derived factors have the potential to control hepatogenesis. The availability of an assay that can be used to measure morphogenic expansion and differentiation of the hepatoblasts in culture should allow the identification of such factors in the near future (Matsumoto et al., 2001 ).
Transcription factors and their roles in controlling hepatogenesis
The tissue interactions described above define the precise location and timing of hepatogenesis during embryonic development. However, the mechanisms by which the cells of the endoderm actually follow and adopt a hepatic fate are best considered as intracellular responses to these signaling events. Large changes in the patterns of genes expressed accompany the differentiation of ventral endoderm cells toward a hepatic phenotype. It therefore seems logical that specific transcription factors will play important roles during liver development, because gene expression is largely regulated through transcriptional control (Cereghini, 1996; Duncan, 2000) . Recently, a number of transcription factors that are candidates to regulate various aspects of hepatogenesis have been identified through studies using both molecular genetic and molecular biology techniques (Fig. 2) . Fig. 2 . Diagram illustrating stages of liver development (underlined) that are affected by specific transcription factors discussed in the text. At gastrulation the definitive endoderm (yellow) is rendered competent to follow a hepatic fate due to the action of HNF3 and Gata factors. Transcription factors that are expressed in response to inductive signals from the precardiac mesoderm (green) and septum transversum mesenchyme (blue) which regulate commitment of the endoderm to a hepatic fate have not been defined. After specification a swelling of the ventral endoderm generates the liver bud in a process that requires both endothelial cells (red) and Hex for completion. The pre-hepatic cells then delaminate from the foregut and migrate into the septum transversum. This process is disrupted in Prox1 knockout embryos. Knockouts in several genes, including Hlx, c-Jun, Xbp1, and NF-kB, disrupt growth and expansion of the hepatoblasts. Concurrent with this phase of rapid proliferation the hepatic cells differentiate and express several genes that are required for hepatocyte function in a process that requires Hnf4a.
Transcription factors that control the potential of the endoderm to follow a hepatic fate
For convenience, development of the hepatic parenchyma can be considered in distinct developmental stages, although it is likely that these processes intertwine and overlap (Fig.  2) . Initially the definitive endoderm must be competent to interpret and respond to signals that induce the hepatic developmental program. In response to the inductive signals described above, the ventral endoderm cells become specified and then committed to a hepatic fate. As the hepatoblasts expand into the septum transversum they begin to differentiate, a process that continues until several days after birth, and express genes that are characteristic of a mature hepatocyte phenotype. The combined actions of morphogenesis and differentiation finally sculpt the liver into a functioning organ.
Competency describes the innate ability of a cell type to follow a given developmental path if it is exposed to the appropriate inductive signals (Gilbert, 2000; Waddington, 1940) . As was discussed above, Gualdi et al. using a tissue explant culture assay, demonstrated that both ventral and dorsal aspects of the endoderm had the potential to express Albumin mRNA if placed in a receptive environment. In the case of ventral endoderm this required alignment with cardiac mesoderm, and for the dorsal endoderm this meant separating it from surrounding tissues (Gualdi et al., 1996) . The mechanisms controlling whether a given cell type is competent or not to follow a defined fate have only recently begun to be understood. Competency could be controlled through expression of the correct repertoire of receptors or compatible signal transduction proteins that allow interpretation of the inductive signals within the embryonic environment. However, a series of reports from the Zaret laboratory have elegantly outlined a mechanism whereby the transcription factors Hnf3 (FoxA) and Gata4 could modulate competency intracellularly Chaya et al., 2001; Cirillo et al., 2002 Cirillo et al., , 1998 Cirillo and Zaret, 1999; Gualdi et al., 1996; Shim et al., 1998) .
In vivo footprinting analyses of the Albumin enhancer using extracts from E9.5 liver buds showed that several binding sites, including the Hnf3, Gata and NF-1 sites, were occupied. In contrast, when extracts from gut endoderm, a tissue competent to follow a hepatic fate but uncommitted and not expressing albumin, were used in the footprinting assay only the Hnf3 and Gata sites were occupied Gualdi et al., 1996) . This implied that Hnf3 and Gata factors could bind silent 'hepatic' enhancers and mark them as having the potential to be expressed following induction. Functional analyses of Hnf3 and Gata4 have shown that they have the unexpected capacity to recognize their respective binding sites in the context of compacted chromatin (Chaya et al., 2001; Cirillo et al., 2002 Cirillo et al., , 1998 Shim et al., 1998) . In addition, using in vitro chromatin reconstitution assays it was shown that the binding of either Hnf3 or Gata4 resulted in the opening of compacted chromatin (Cirillo et al., 2002) . Importantly, this was found to be an intrinsic property of these transcription factors and not due to the recruitment of secondary factors, such as histone acetylases, which could indirectly affect chromatin structure by modulating histone binding. Compacted chromatin is generally considered to inhibit efficient gene transcription (Ayer, 1999; Barton and Crowe, 2001) . This means that reorganization of chromatin structure can potentially be used to control gene expression and, therefore, the response of cells to inductive events. The fact that both Hnf3 and Gata4 can remodel chromatin structure after binding suggests that they could generate a receptive chromatin structure around 'hepatic' enhancers rendering them available for occupancy by transcriptional activators whose own expression or activity was controlled through extracellular inductive events. Support for this model comes from the finding that Hnf3 can relieve transcriptional repression of the a -fetoprotein gene in in vitro transcription assays that use chromatin-assembled DNA templates (Crowe et al., 1999) .
Molecular analyses of the Hnf3 and Gata factors clearly support the idea that they can act as potentiators of hepatic fate. Two members of the Hnf3 family of factors, Hnf3a and Hnf3b, are expressed throughout the definitive endoderm prior to the inductive events that specify the hepatic fate within the ventral endoderm (Altaba et al., 1993; Ang et al., 1993; Monaghan et al., 1993; Sasaki and Hogan, 1993) . Targeted disruption of the Hnf3a gene did not effect early embryonic development, suggesting that either it is dispensable or that Hnf3b compensates for its loss (Kaestner et al., 1999; Shih et al., 1999) . In contrast, Hnf3b 2/2 embryos showed defects in formation of the node, notochord and development of the floorplate of the neural tube. In addition, these embryos had defects in the formation and morphogenesis of the foregut endoderm that prevented the association of any endoderm with the inductive tissues that specify hepatic development (Ang and Rossant, 1994; Dufort et al., 1998; Weinstein et al., 1994) . Unfortunately, this meant that a requirement for Hnf3b in defining the competency of the endoderm could not be directly addressed using Hnf3b 2/2 embryos. A similar situation exists for the Gata factors. Although Gata4 has been shown to bind the Albumin enhancer it has yet to be demonstrated that Gata4 is expressed in the endoderm during the onset of hepatic development. Transgenic studies using a LacZ 'knock-in' allele and in situ hybridization analyses have shown that the closely related Gata factor, Gata6, is expressed in the foregut around the time development of the liver initiates (Koutsourakis et al., 1999; Morrisey et al., 1996) . Both Gata4 2/2 and Gata6 2/2 embryos arrest during development prior to the onset of hepatogenesis. Gata6 2/2 embryos die prior to gastrulation and Gata4 2/2 embryos show defects in foregut morphogenesis similar to those of Hnf3b 2/2 embryos (Keijzer et al., 2001; Koutsourakis et al., 1999; Kuo et al., 1997; Molkentin et al., 1997; Morrisey et al., 1998) . The developmental arrest in both Gata4 2/2 and Gata6 2/2 embryos seems to be primarily due to defects in extraembryonic tissues. This implies that complementation of Gata null embryos with a wild type extraembryonic endoderm should complement the deficiency and allow an analysis of the role of these factors in potentiating hepatic development. It should be possible to achieve this by tetraploid embryo complementation. This requires that Gata 2/2 ES cells are combined with embryos made tetraploid by electrofusion. In the resulting chimeric embryos the extraembryonic endoderm is derived from tetraploid cells, whereas the fetuses are derived solely from the ES cells . Such a 'rescue' has been performed successfully on other transcription factors that affect development of both extraembryonic endoderm and liver (Barbacci et al., 1999; Coffinier et al., 1999; Dufort et al., 1998; Li et al., 2000) . More evidence that such an approach should be successful comes from Narita et al. who have shown that wild type extraembryonic endoderm does at least partially complement the Gata4 2/2 phenotype, although development of the liver was not analyzed in these experiments (Narita et al., 1997 ).
Loss of either Hex or Prox1 affect early stages of liver development
Hex (also called Prh) encodes a divergent homeobox transcription factor. Analyses of the expression of Hex mRNA showed that it was highly expressed throughout the ventral endoderm at the early headfold stage (pre-somite; ,E8.0), which is prior to the apparent initiation of hepatogenesis. By the 10 somite stage (,E8.5) expression within the ventral endoderm becomes restricted to two discrete areas that are the future sites of the liver and thyroid (Keng et al., 1998; Thomas et al., 1998) . This early expression of Hex mRNA within the liver anlage defines Hex as amongst the earliest markers of the developing liver. Two groups independently generated Hex 2/2 embryos to address the role of Hex during early development (Keng et al., 2000; Martinez Barbera et al., 2000) . Both groups reported a dramatic loss of the fetal liver parenchyma in midgestation mouse embryos. Keng et al. reported that although the parenchymal cells were lost in the mutant embryos a 'liver-like capsule' was identified that contained sinusoidal spaces filled with hepatopoietic cells (Keng et al., 2000) . Analyses of Hex 2/2 embryos at E9.5 to E10.5 revealed that the ventral endoderm began to thicken but, in contrast to control embryos, expansion or morphogenic outgrowth of the liver bud was undetectable (Keng et al., 2000; Martinez Barbera et al., 2000) . Consistent with the failure of the Hex mutant embryos to form a liver bud, both groups found that expression of markers of hepatic differentiation were perturbed. Whole mount in situ hybridization analyses showed that a-fetoprotein mRNA was absent within the liver bud at both E9.5 and E10.5, while RT-PCR analyses of E8.5 whole embryos showed an absence of Albumin mRNA expression (Keng et al., 2000; Martinez Barbera et al., 2000) . Taken together these data show that Hex is essential for very early aspects of hepatic development. The fact that a swelling of the endoderm can be detected, even though hepatic gene expression remains undetectable, suggests that specification of the hepatic lineage occurs. Nevertheless, the phenotype exhibited by Hex 2/2 embryos is the earliest perturbation to hepatogenesis so far described.
Knockout studies have also revealed a role for a second homeobox transcription factor called Prox1 during early stages of hepatic development. Prox1 was initially cloned through homology to the Drosophila gene Prospero (Oliver et al., 1993) . In situ hybridization analyses indicated that it was expressed in a variety of tissues including the developing liver (Oliver et al., 1993) . Prox1 2/2 embryos were generated by disrupting exon 1 through the insertion of a bacterial LacZ reporter gene. The reporter gene was positioned in-frame with the Prox1 coding sequence, which allowed the use of b-galactosidase activity to trace Prox expression in Prox1 1/2 and 2/2 embryos (Wigle et al., 1999) . Using this approach, Sosa-Pineda et al. identified expression of Prox1/b Gal activity in the developing liver bud at E9.0 (Sosa-Pineda et al., 2000) . Analyses of Prox1 2/2 embryos found that at E14.5 the livers of the mutant embryos were significantly smaller than those of controls. Moreover, although the mutants formed distinct liver lobes the hepatic parenchymal cells were restricted to a central rudiment (Sosa-Pineda et al., 2000) . Similarly, when embryos were examined at earlier stages, from E10 through E12.5, hepatoblasts were absent from the developing liver lobes, instead remaining clustered within a central core. Two characteristics of Prox1 2/2 hepatoblasts explained their failure to inhabit the mesenchymal portion of the liver. First, BrdU-labeling in vivo demonstrated that proliferation of Prox1 2/2 hepatoblasts was markedly reduced compared to controls, implying that the overall numbers of hepatoblasts were reduced in the mutant embryos. Furthermore, at E10 while control hepatoblasts were seen to migrate as cords into the surrounding septum transversum, Prox1 2/2 cells failed to delaminate from the liver diverticulum. Expression of E-cadherin, which mediates cell-cell contacts, is normally down-regulated as the hepatoblasts migrate. In keeping with the defect described above, immunostaining experiments showed that in Prox1 2/2 embryos high levels of E-cadherin were maintained within the liver anlage. Although the Prox1 2/2 hepatoblasts failed to expand and migrate they were able to express Albumin and a-fetoprotein implying that the cells had been specified to follow a hepatic fate (Sosa-Pineda et al., 2000) . In sum, these data demonstrate that while Prox1 is dispensable for hepatic specification it is required for morphogenic expansion of the liver primordium.
While the study of knockout embryos has clearly implicated both Hex and Prox1 as having important roles in controlling hepatogenesis, there is much less known about the precise function of these transcription factors. In the case of Hex, there is some evidence that it can act as a transcriptional repressor. When cells were co-transfected with a plasmid expressing a Hex-Gal4-DNA-binding domain fusion protein, expression of a Gal4-mediated expression of a reporter plasmid was inhibited (Tanaka et al., 1999) . In contrast, however, studies of the Na 1 -dependent bile acid cotransporter (Ntcp) gene have identified a regulatory element through which Hex activates transcription in hepatoma cells (Denson et al., 2000) . Indeed, Ntcp is the first and only known target of Hex. Whether Hex encodes an activator or repressor of transcription will clearly require further study; however, it is also possible that its function is dependent upon the context of the regulatory sequences to which it binds. Regardless, it will be necessary to identify additional target genes of both Hex and Prox1 if one is to begin to understand the mechanisms through which these factors control the early stages of hepatic development.
Transcriptional regulation of hepatocyte differentiation
During the 1980s an enormous effort by many labs allowed the identification of transcription factors that bound transcriptional regulatory elements of genes that were predominantly expressed in the liver (Lai and Darnell, 1991; Sladek and Darnell, 1992) . These included Hnf1a and b (vHnf1), the c/EBP family, Hnf3a, b, and g, Hnf4a, and more recently Hnf6 (Lai and Darnell, 1991; Lemaigre et al., 1996; Samadani and Costa, 1996; Sladek and Darnell, 1992) . Knockout mice have been generated for all of the genes encoding these factors and analyses of these mice have revealed that loss of a single factor generally has negligible effect on hepatocyte differentiation. For example, disruption of either Hnf3a, Hnf3b or Hnf3g in the liver does not affect hepatocyte differentiation, although moderate changes in expression of a subset of hepatocyte genes have been described (Kaestner et al., 1998 (Kaestner et al., , 1999 Shih et al., 1999; Sund et al., 2000) . Although this may be due to functional redundancy, it is worth noting that specific disruption of Hnf3b in the pancreatic b-cells disrupts b-cell differentiation and islet morphology even though these cells express Hnf3a (Kaestner et al., 1999; Sund et al., 2000) . Disruption of some genes does have serious consequences on liver function, however. For example, although early liver development is normal in c/EBPa 2/2 embryos the neonates die from hypoglycemia due to a failure of the liver to accumulate glycogen . In these mice, expression of glycogen synthase is disrupted and the bile canaliculi form abnormally . In addition, although fetal livers develop normally, hepatocyte proliferation was found to increase in newborn c/EBPa 2/2 livers (Timchenko et al., 1997 ). This appears to be due to the fact that c/EBPa inhibits cell proliferation by stabilizing the cyclin dependent kinase inhibitor p21 and by regulating S-phase-specific E2F-p107 complexes (Harris et al., 2001; Timchenko et al., 1997 Timchenko et al., , 1999 . Targeted disruption of the Hnf1a gene also had no obvious effect on development of the liver; however, mice lacking Hnf1a suffer from multiple different symptoms that differ depending upon the nature of the targeted allele. In one case, mice suffered from hepatic dysfunction, renal Faconi's syndrome, and phenylketonuria, while a different gene targeting strategy generated mice that suffered from Laron dwarfism and non-insulin-dependent diabetes mellitus (NIDDM). The development of phenylketonuria in these mice results from loss of expression of the phenylalanine hydroxylase (Pah) gene due to the inability of Hnf1a to facilitate modification of chromatin around the Pah promoter (Pontoglio et al., 1996 (Pontoglio et al., , 1997 . Interestingly, Hnf1a-mediated histone modification may also be required for expression of the Glut2 and Pyruvate kinase genes in the pancreas but not in the liver suggesting that this mode of regulation is tissue specific (Parrizas et al., 2001) . The fact, however, that many mutations do not appear to disrupt hepatocyte differentiation is consistent with the concept that transcription factors act cooperatively to coordinate gene expression. The majority of promoters bind multiple factors and, therefore, it seems reasonable that the loss of a specific factor can be compensated for by the binding of the remaining complement of transcriptional regulatory proteins present within the cell. Nevertheless, while this model may be generally applicable it has recently been demonstrated that during development of the fetal liver the nuclear hormone receptor, Hnf4a, is essential for expression of a large array of genes that define hepatocyte function (Li et al., 2000) .
Analysis of the expression of Hnf4a mRNA found it to be first expressed in the primitive endoderm of the blastocyst concurrent with implantation . The first expression in the embryo proper was identified in the developing liver bud and hindgut at around the 10 somite stage Taraviras et al., 1994) . Prior to this developmental stage expression of Hnf4a mRNA was restricted to the extraembryonic visceral endoderm, which forms the endodermal portion of the yolk sac. Studies using rat/human fibroblast hybrid cell lines and somatic hepatoma cell variants that had de-differentiated found that the presence or introduction of Hnf4a strongly correlated with a hepatic cell phenotype (Bulla, 1997; Bulla and Fournier, 1994; Griffo et al., 1993; Spath and Weiss, 1997) . This work implied that Hnf4a acted as an important regulator of hepatocyte differentiation. Moreover, analyses of the Hnf1a transcriptional regulatory elements had identified the presence of an Hnf4a binding site, and transfection studies using tissue culture demonstrated that Hnf4a could positively regulate expression through the Hnf1a promoter (Kuo et al., 1992; Tian and Schibler, 1991) . Consistent with this finding, developmental expression of Hnf4a slightly precedes that of Hnf1a in a number of tissues in which both factors are expressed (Blumenfeld et al., 1991; Duncan et al., 1994; Taraviras et al., 1994) . Cumulatively these data suggested a model in which Hnf4a controls hepatocyte differentiation through the activation of a cascade of transcription factors that ultimately define the gene expression profile of the mature hepatocyte. Hnf4a 2/2 embryos arrest during gastrulation, prior to the onset of hepatogenesis, due to defects in visceral endoderm function Duncan et al., 1997) . Unfortu-nately, this phenotype prevented the use of these embryos to study any role for Hnf4a in controlling hepatocyte differentiation. However, it was demonstrated that the developmental arrest associated with Hnf4a 2/2 embryos could be rescued by providing a wild-type extraembryonic endoderm through tetraploid embryo complementation Li et al., 2000) . Using this procedure it was found that clonal embryos generated from Hnf4a 2/2 ES cells were viable until E12.0. Due to technical limitations not associated with Hnf4a the embryos died shortly after this stage. A comparison of livers from embryos generated from either control or Hnf4a 2/2 ES cells found them to be morphologically and histologically indistinguishable. Although the hepatoblasts at this stage in hepatic development are relatively immature they have initiated expression of genes that define the mature hepatocyte phenotype. When the mRNA levels from such genes was compared between control and Hnf4a 2/2 livers it was found that the expression of 14 genes that have important roles in hepatocyte function were either down-regulated or in some cases undetectable in the absence of Hnf4a (Li et al., 2000) . These results have also recently been confirmed in adult hepatocytes that lack Hnf4a (Hayhurst et al., 2001) . These data strongly support the proposal that Hnf4a is a central regulator of hepatocyte differentiation. However, it will be necessary to look at later developmental stages to directly confirm this model and to assess the consequences of loss of Hnf4a function on hepatocyte morphology and liver structure. The recent description of mice harboring a conditionally null allele of Hnf4a should facilitate such analyses (Hayhurst et al., 2001; Parviz et al., 2002) .
In this review, we have focused on a select group of transcription factors that affect specific aspects of hepatogenesis. However, gene-targeting studies have identified several other transcription factors and signal transduction molecules that, when mutated, result in hypoplasia within the fetal livers Eferl et al., 1999; Hilberg et al., 1993; Johnson et al., 1993; Reimold et al., 2000; Schmidt et al., 1995; Uehara et al., 1995) . It has been proposed in other reviews of this topic that these factors, which include HGF, cMET, c-Jun, SEK1 (MKK4), and Xbp1, form a pathway that results in the activation of genes that control cell proliferation (Duncan, 2000; Zaret, 1998) . In addition, mutations that affect NF-kB signaling also result in hypoplasia, which is due to increased apoptotic cell death of the differentiating hepatocytes (Duncan, 2000) . Interestingly, deletion of TNFa or the TNFa receptor suppresses the phenotype of NF-kB signaling-deficient mice. This implies that the role of NF-kB signaling during hepatogenesis is to inhibit TNFa-mediated cell death (Doi et al., 1999; Li et al., 1999; Rosenfeld et al., 2000) .
Conclusions and future directions
The combined use of molecular genetics, molecular biology and embryology has allowed us to realize great advances in the understanding of the mechanisms that control hepatogenesis. However, as with all science these advances raise many more questions -some new and some old.
Clearly the discovery that endothelial cells are essential for expansion and morphogenic outgrowth of the hepatic primordia implies that specific signals are being displayed or released from the endothelial cells that are necessary for this process. Sinusoidal endothelial cells are a rich source of secreted substances (Kmiec, 2001) . For example, they are known to synthesize several cytokines and growth factors including HGF, basicFGF, TGF-b1 and 2, interleukins-1a and b, -6 and -18 (Bissell et al., 1995; De Bleser et al., 1997; Feder et al., 1993; Knolle et al., 1997; Lohse et al., 1996; Maher, 1993; Rieder et al., 1993 Rieder et al., , 1987 Rosenbaum et al., 1989; Vidal-Vanaclocha et al., 2000) . The fact that these endothelial cells secrete such a large number of proteins with known roles in liver development is clearly provocative. In addition, sinusoidal endothelial cells have been shown to secrete components of the extracellular matrix including laminin, collagen types I, III and IV, and fibronectin (Geerts et al., 1993; Herbst et al., 1997; Irving et al., 1984; Neubauer et al., 1999; Rieder et al., 1987) . The requirement for the ECM during hepatocyte differentiation may imply that the hepatic endothelial cells will have additional regulatory functions during later stages of development. A similar state exists for the septum transversum. Only recently have markers become available that are expressed in septum transversum mesenchymal cells and distinguish them from hepatocytes. If promoter elements driving expression of such markers could be identified they could allow the generation of transgenic mice driving Cre within these cells. This would allow septum transversum-specific gene ablation by breeding these mice with desirable 'floxed' alleles. This could be important, for example, to definitively demonstrate that BMP action in controlling hepatogenesis originates from the septum transversum.
The identification of transcription factors like Hex and Prox1 that are essential for very early aspects of hepatogenesis is also exciting. However, as mentioned earlier, the mechanism of action of these factors is not well understood. Do these factors interact with other proteins to coordinate expansion of the hepatic analage and what are the target genes that mediate their role in controlling liver development? Also, since these factors act so early in the genesis of the liver it will be important to understand the mechanisms controlling their expression. Interestingly, analyses of the Hex proximal promoter identified both Hnf3b and Gata4 as regulators of Hex expression in tissue culture cells (Denson et al., 2000) . This may imply a direct link between factors that regulate competency of the endoderm (see above) and those that are required for the earliest stages of hepatogenesis. However, to make any irrefutable claim that control of Hex expression is a direct consequence of earlier develop-mental events will require detailed characterization of the Hex regulatory elements in transgenic mice. Indeed preliminary analyses along these lines have identified regions of Hex genomic DNA that can regulate liver bud expression in transgenic mice (Rodriguez et al., 2001) . Given that Hex and Prox1 have such crucial roles in expansion of the liver bud it would not be unreasonable to think they make additional contributions during later stages of hepatogenesis. This possibility could be addressed by generating mice harboring conditional alleles in these genes.
The value of the Cre/loxP system for conditionally ablating genes in specific cell types cannot be overstated. During embryogensis specific proteins are utilized time and time again to control disparate developmental procedures. Standard global knockouts identify the first indispensable requirement for a given factor. For example, knockouts in Hnf4a, Hnf1b, Gata4 and Gata6 all result in embryonic lethality due to an essential requirement for these proteins in extrembryonic tissue development. These deficiencies have to be overcome in order to understand the role of these factors during hepatogenesis. The number of conditionally null alleles available has increased dramatically. Combined with the greater availability of different varieties of transgenic mice expressing Cre it is likely that we will see a dramatic increase in the number of genes required for the various stages of hepatogenesis.
